Company Filing History:
2 out of 36 
1 out of 1 
1 out of 2,010 
Years Active: 1998-2000
Title: Michelle Letarte: Innovator in Medical Diagnostics and Therapy
Introduction
Michelle Letarte is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of medical diagnostics and therapy, particularly in relation to hereditary conditions. With a total of 4 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents focuses on the diagnosis and therapy for hereditary hemorrhagic telangiectasia (HHT). This innovative method includes steps for the recombinant production of soluble TGF-β-binding endoglin. The invention provides a novel purified TGF-β-binding glycoprotein, endoglin, along with an isolated nucleic acid molecule that encodes an amino acid sequence corresponding to this glycoprotein. Additionally, it includes a pharmaceutical composition that comprises the endoglin-derived polypeptide, which can be purified or produced through recombinant methods, along with a pharmaceutically acceptable carrier. This composition is designed for treating patients suffering from HHT.
Career Highlights
Throughout her career, Michelle has worked with notable companies such as HSC Research and Development Limited Partnership and Telios Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Michelle has collaborated with esteemed colleagues, including Joan Massague and Carmelo Bernabeu. These partnerships have further enriched her research and development efforts.
Conclusion
Michelle Letarte stands out as a dedicated inventor whose work in medical diagnostics and therapy is paving the way for advancements in treating hereditary conditions. Her contributions are invaluable to the field and hold promise for future innovations.